Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways

Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug associated with anti-tumorigenic and pro-apoptotic properties in animal and in vitro models of cancer. However, the underlying cellular mechanisms by which TA exerts its effects are only partially understood. Activating transcription fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seong-Ho, Bahn, Jae Hoon, Whitlock, Nichelle C., Baek, Seung Joon
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940954/
https://www.ncbi.nlm.nih.gov/pubmed/20581861
http://dx.doi.org/10.1038/onc.2010.251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940954/
https://www.ncbi.nlm.nih.gov/pubmed/20581861
http://dx.doi.org/10.1038/onc.2010.251

Ejemplares similares